1-deoxynojirimycin has been researched along with Cytomegalovirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizuno, S; Nishiyama, Y; Saga, S; Shimokata, K; Tsurumi, T; Yamashita, Y | 1 |
| Daikoku, T; Mizuno, S; Nishiyama, Y; Shimokata, K; Tsurumi, T; Yamashita, Y | 1 |
2 other study(ies) available for 1-deoxynojirimycin and Cytomegalovirus
| Article | Year |
|---|---|
Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.
Topics: 1-Deoxynojirimycin; Cell Line; Cytomegalovirus; Embryo, Mammalian; Endoplasmic Reticulum; Glycoside Hydrolases; Golgi Apparatus; Histocompatibility Antigens Class I; Humans; Kinetics; Lung; Macromolecular Substances; Oligosaccharides; Protein Processing, Post-Translational; Temperature | 1994 |
Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.
Topics: 1-Deoxynojirimycin; Calcium-Binding Proteins; Calnexin; Cell Line; Cytomegalovirus; Glycosylation; Humans; Indolizines; Molecular Chaperones; Oxidation-Reduction; Protein Binding; Protein Folding; Protein Precursors; Protein Processing, Post-Translational; Tunicamycin; Viral Envelope Proteins | 1996 |